- Home
- XLO vs PHUN Comparison
XLO vs PHUN Comparison
Compare XLO & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XLO | PHUN |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8M | 44.4M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | XLO | PHUN |
|---|---|---|
| Price | $8.48 | $2.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $28.00 | $7.25 |
| AVG Volume (30 Days) | 33.3K | ★ 150.1K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.36 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,766,000.00 | $30,883,000.00 |
| Revenue This Year | N/A | $89.86 |
| Revenue Next Year | $168.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 589.88 | 15.57 |
| 52 Week Low | $0.46 | $1.56 |
| 52 Week High | $9.25 | $3.88 |
Technical Indicators
Market Signals| Indicator | XLO | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 60.59 | 50.86 |
| Support Level | $0.62 | $1.79 |
| Resistance Level | $8.66 | $2.30 |
| Average True Range (ATR) | 0.50 | 0.12 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 68.13 | 51.28 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.